Researchers led by the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) have received $7 million from the National Institutes of Health (NIH) to expand a clinical trial studying rapamycin’s ability to extend the lives of companion dogs as part of The Dog Aging Project (DAP).

The DAP is a collaborative, community scientist-driven, data-gathering research project that launched in 2019 as a joint effort between the University of Washington School of Medicine and Texas A&M, with other collaborating institutions. It enrolls companion dogs from all backgrounds to study the effects of aging and gain a better understanding of what contributes to a long and healthy canine life, which also helps to expand medical knowledge surrounding human aging. To date, more than 50,000 dogs have been enrolled in the study.

Test of Rapamycin In Aging Dogs (TRIAD) is the third DAP clinical trial involving rapamycin, a generic drug that has long been used as an immunosuppressant during organ transplants in people. Previous DAP studies have shown that in small doses, the drug appears to improve cardiac function in dogs.

To enroll in either the DAP or TRIAD, owners can visit the DAP’s website. Owners interested in TRIAD can take a preliminary “fast track” survey to find out if their dog is likely to be accepted to the TRIAD study.

Read the full article: Dog Aging Project Receives $7 Million NIH Grant To Expand Clinical Trial Of Anti-Aging Drug - Texas A&M Today

相关阅读:

26 Likes

Great news! Good start! Maybe finally there will be more trials.

7 Likes

Yay, good news, glad to hear this.

2 Likes

Great to see this get funded and moving forward!!

2 Likes

The Dog Aging Project, the first large-scale, longitudinal study of large animals in a natural environment, suggests that low doses of rapamycin could increase dogs’ lifespan, improving both their heart and cognitive functions by regulating cell growth and metabolism.

“Our study is light years ahead of anything that’s been done on humans or can be done on humans,” said Daniel Promislow, a biogerontologist at the University of Washington and a co-director of the project. “What we’re doing is the equivalent of a 40-year-long study on humans, testing the ability of a drug to increase healthy lifespan.”

Kate Creevy, co-founder and chief veterinary officer of the project, said they were in the unique position of being able to split their findings not just by male and female dogs – but also pre- and post-spaying, or surgical sterilisation.

“This means that our research could have interesting translational impacts for women pre- and post-menopause,” said Creevy. “We also have data on what age dogs have been spayed – which could cross over to the variation in age that women have their menopause – and data on why they were spayed, which could cross over to women who have had hysterectomies for medical reasons.”

Source: Scientists explore longevity drugs for dogs that could also ‘extend human life’ | Ageing | The Guardian

5 Likes

Is Matt still involved?

2 Likes

It looks like it. He is still listed as a director on their website: Our Team - Dog Aging Project

6 Likes

I haven’t been able to find any protections on when the Dog Aging Project’s rapamycin cohort will produce interim results and final results.

I’ve been taking rapamycin weekly for a year and a half, but I would be heavily/negatively influenced if this project didn’t produce favorable results.

For me, this project constitutes a significant “go, no go” moment in my journey with rapamycin.

Everything I’ve seen is vague. They basically seem to be saying that it will be ready when it’s ready. Surely they can give some kind of ball park estimate!

1 Like

Matt K. told me that he expected some early results in 2026 but that was the thinking prior to the NIA pulling funding on the project last year. I have no idea how the cessation of funding, and now the refunding of the effort, has impacted the schedule.

Given that we have the positive results in monkey, which are evolutionarily much closer to humans, I think the dog study is less important now (though still very interesting).

7 Likes

Good point!

My understanding was that the marmoset study had a relativity small number of participants and the marmosets were locked up in a lab.

I like the dog study because it has a larger sample, the dogs are genetically diverse and they will likely be experiencing a wide range of physical activity.

I’ve particularly concerned about the last point, “physical activity”.

So far, the rapamycin studies have all been conducted on the animal equivalent of a couch-potatoes.

I worry that mtor1 regulation with rapamycin might be an analog for exercise and may only benefit people who are sedentary, like lab mice and lab marmosets.

We’ve already seen a comperable phenomena with metformin. In that case, Type 2 Diabetics seem to experience a longevity benefit, but people with healthy metabolisms/diets don’t seem to experience any worthwhile effect.

Unless I’m missing something, the Dog Aging Project is the only study in large mammals that comes close to measuring the benefit for the types of people likely to follow this forum.

I’m guessing the average longevity enthusiast is in the upper range of fitness and lifestyle. We’re more likely to live like a domestic dog, enjoying regular walks, portion control and regular visits to the vet. :grinning:

2 Likes

Yes - 66 Marmosets or so I think. The paper hasn’t come out yet, so I don’t know the details. I don’t think marmosets are bred like mice, so I believe some significant genetic diversity in the group.

Its an interesting question regarding the level of physical activity of the monkeys. I’m not sure how large the cages are, and the level of activity that you naturally see in these species. When the paper comes out, this could be an area we can ask Adam Salmon more about.

But I’m not super confident that American dogs are going to be a whole lot different than the typical humans (average American exercise regimen) or the monkeys.

When I go out walking my dog, it seems most dogs mirror the eating and exercise habits of their owners. So I’m not sure we’ll really get the data we’d like to see - which is on a dog cohort that is very well exercised, fed a very healthy diet, and rapamycin (vs. just the well exercised and fed cohort).

2 Likes

Clearly, I’m just guessing, but…

The average American dog probably gets more exercise than the average American. Owning a dog forces people to go for walks more than most ordinary Americans.

Three average dog almost certainly gets more exercise than a lab animal, unless the lab animal is specifically made to exercise.

My understanding is that the dog study is powered to detect a 10% benefit.

If even some of the dogs are getting a decent amount of exercise and rapamycin is an analog for exercise, the result will probably be less than 10% and the study will be inconclusive.

Let me put it this way. If the dog study is inconclusive I will probably stop taking rapamycin, since I exercise every day.

2 Likes

Matt had clearly hinted at positive interim data from this project in his interviews but he was noncommittal as of course he should be.

But if you listen closely it’s clear which way the wind is blowing.

6 Likes

I don’t think so. Exercise (may vary by type) actually activates m-tor in the muscle, heart and brain and inhibits m-tor in the liver and fat cells.

Rapamycin seems to be more an analog for fasting/fast mimicking diet as it activated strongly by leucine, arginine as wells as glucose.

It’s also activated by hormones insulin and androgens that can mitigate negative effects of growth factors in terms of cancer.

4 Likes

I agree with Dr.Bart here - generally, when it comes to mTOR rapamycin and exercise are diametrically opposed. But, as I was thinking about this I also realized that I’ve read that exercise is a key method of increasing autophagy so perhaps there are some portion of overlap in their effects; biology is complex.

See this post: What’s autophagy? It’s the ultimate detox that doesn’t yet live up to the hype - #7 by RapAdmin

相关:

4 Likes

I’m not an expert, but it’s my understanding that exercise (particularly aerobic exercise) and fasting both produce a hormesis effect. Autophagy may be one of many sideffects they have in common.

A lab animal lounging in a cage is in the unusual state of zero hormesis.

A pet dog goes for walks, chases other dogs, etc. (Incidentally, it’s also well documented that pet owners often take better care of their pet’s diet than their own.)

Obviously, a population of hundreds of dogs will vary in the exercise they get. But collectively they definitely get a lot more than a cage animal and probably get more than the average American.

It’s my view that a lab animal is a good analog for a sick person. Someone who is housebound or invalid. Not an analog for the people who are interested in anti-aging.

By contrast, the population of people who are following these studies religiously (the sorts of folks who participate in this forum and take rapamycin off label) are more likely to exercise regularly, eat sensibly and take care of their health.

If the Dog Aging Project produces a favorable result, I hope the research community takes note of the importance of this distinction. Otherwise I fear a lot of research done on sedentary lab animals could be a waste of precious resources.

1 Like

Sure, they are all stressors or cause “hormesis”, so is heat/cold exposure and rapamycin intake - technically. However it doesn’t mean you can simply conflate the effects of each. Heat exposure is not the same as fasting and rapamycin is NOT an analogue for exercise.

To make a blanket statement that lab rats are in state of ZERO hormesis is absolutely false. The advantage of lab animals is you can design an experiment with quantifiable amount of stressors - whether that is exercise, fasting, specific diet, environmental exposure, etc… That is extremely difficult with humans, unless you put them in the lab, which is rarely done for obvious reasons.

The reason why testing rapamycin on dogs may translate better to humans because of similar environmental exposure - pollutants, pathogens, even food. Exercise is definitely not one of them.
Our dog for example is a cavalier and she it not fond of exercise, where a dog like Vizsla can run marathons. BTW, these level of activity differences mirror human beings, from sedentary to triathalon amateur athletes.

1 Like

I can tell you that I am not sedentary and I have seen multiple benefits from rapamycin related to immune system improvements. The most noticeable is the elimination of allergies. The second most noticeable is the dramatic reduction in illnesses (colds, mostly); I almost never get sick anymore.

Will I live longer? IDK

3 Likes

Here is the very fundamental flaw in your hypothesis: it was tested, and has failed.

Really, it’s the very first question you should have asked yourself. Does exercise extend lifespan in mice?

If your thesis is that sedentary mice in a lab setting are a poor model for life extension interventions, because whatever drug is tried - like rapamycin - it will at best replicate the life extending effects of exercise, then ask: but does exercise extend the life of mice?

And the answer is: NO. Exercise enhances the general health, prevents frailty and a variety if diseases, lowers the mortalty risk, but does not, repeat, does NOT extend lifespan in mice (or humans). No organism, including human has broken the longevity barrier for the species with an exercise intervention. If the lifespan of a mouse is roughly 900 days (depending on the strain of mice), exercising the mouse will drastically raise the odds that the mouse will actually hit the 900 days - it will prevent the premature death of the mouse. It is called “squaring the curve”. If you take a group of sedentary mice, you will start having some of them die early, like at 400 days, some at 500, 600, 700, and so on, and finally most mice will die at the natural limit of about 900 days. So as the mice age, the survival curve for the group slopes down as fewer and fewer mice survive. But you take a group of mice and exercise them, and now the survival curve looks very different - very few mice drop dead along the way at 400, 500, 600 days, the curve for the surviving group dosn’t slope down - it keeps straight… until about 900 days, when it nosedives straight down at close to 90 degrees, as almost all the mice die out. You’ve squared the curve of survival, you have not extended it.

It’s the exact same situation in humans. You take a group of people and exercise them lifelong, and you prevent most from dying prematurely - from heart attacks, frailty and many diseases as the average sedentary human does. But you don’t break any longevity barriers. You don’t end up with supercentenarians who all exercised. Athletes live healthfully a full lifespan - which most sedentary don’t - but they are not particularly prevalent in the very old (look up the statistics of average lifespan - athletes only gain a few years compared to nonathletes). In all animal and human models, the survivors who go much beyond the average lifespan are genetic outliers - not exercisers.

Life-long spontaneous exercise does not prolong lifespan but improves health span in mice

Conclusion

“Life-long spontaneous exercise does not prolong lifespan but improves healthspan in mice. Exercise is an intervention that delays age-associated frailty, enhances function and can be translated into the clinic.”

Now back to your hypothesis. We know from studies, that another lifespan extending intervention, CR (which incidentally also suppresses mTOR), has been compared to exercise and exercise failed to extend max lifespan, while CR did.

Rapamycin in the many organisms studied, including mice, has extended lifespan, while many other interventions, including exercise, have not.

That’s the entire point. Rapamycin extends lifespan in the organisms studied, worms, flies, mice, dogs(? - hopefully we’ll soon find out), marmosets… and like with all lifespan interventions in humans, we have no data, because the studies would take more than a century.

Again, when generating a hypothesis, the first step is to check whether it has already been studied and refuted. Like exercise.

And a small heuristic, rule of thumb that I use when generating hypothesis. If something extremely obvious occurs to me, like “hmm, I wonder if lab conditions, such as sedentary mice impacts my study, like, say, exercise”, I first, before going any further, put together some facts, and some probabilities. Fact: there are literally thousands of extremely smart, dedicated and careful scientists who are conducting these studies. Probabilities: what are the odds, that this extremely obvious hypothesis that has occured to me - lab conditions, sedentary, exercise confounder - has not occurred to any of these thousands of scientists who have dedicated their lives to this? I’d say extremely remote. Therefore, before I run off with this hypothesis and go far with conclusions, let me check if they have done any studies of my hypothesis. And lo and behold, they have, and I read it with interest.

This doesn’t mean one should not ask oneself these questions - absolutely one should, 100%! If one doesn’t, one learns nothing. I commend anyone asking sensible questions - and this is a very sensible question, yes, it makes total sense to ask whether lab mice being sedentary doesn’t impact the experiment and the result!

I personally exercise, but I take rapamycin to give me a boost beyond what exercise can. I don’t know if it will, but that’s my gamble. Before I took rapamycin, I did extensive research, and since I already exercise, I want something more which I cannot get just from exercise, otherwise, why do it. It’s a gamble… the result of which I may never know - what I’m doing, is playing the odds.

2 Likes

Where are you getting data on humans from?